Alps Advisors Inc Clene Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.1 - $4.12 $134,484 - $263,844	-64,040 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.42 - $4.42 $19,222 - $35,108	-7,943 Reduced 11.03%	64,040 $252,000
Q4 2021 Feb 09, 2022	SELL	$3.95 - $7.53 $12,592 - $24,005	-3,188 Reduced 4.24%	71,983 $295,000
Q3 2021 Nov 15, 2021	SELL	$6.83 - $13.58 $22,491 - $44,718	-3,293 Reduced 4.2%	75,171 $513,000
Q2 2021 Aug 11, 2021	BUY	$6.98 - $13.33 $547,678 - $1.05 Million	78,464 New	78,464 $882,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.